INR:2633. bet365 registration bonus code Merck's P2X3 receptor blocker gefapixant succeeds in two key Phase 3 clinical trials ...

Cambridge: AstraZeneca's Tagrisso (osimertinib) has been approved in the European Union (EU) for the treatment of adult ...

A new study published in the Journal of the National Cancer Institute found that metformin which is frequently used to ...

While millions of people live with chronic obstructive pulmonary disease (COPD), many don’t realize they have it until it ...

Walk down the street, and you see huge billboards and hoardings. There are no ad blockers for this media! Sure you may ignore them, but you can’t block them. :) We have spaced out our ads so ...

This is because the scarring causes the tissues in the lungs to get thick and stiff and makes it hard to absorb oxygen into the bloodstream. Pulmonary fibrosis is an interstitial lung disease.

Puberty blockers are to be banned indefinitely after experts warned of an "unacceptable safety risk" to children. The Government has permanently banned the drugs that halt the sexual development ...

LONDON — The British government indefinitely banned the use of puberty blockers by people under 18 years of age Wednesday after expert advice flagged an "unacceptable safety risk" in their use.

The block has sparked conversation over rights for transgender youth (Picture: PA) Puberty blockers for those under 18 with gender dysphoria will be banned indefinitely, the government has announced.

Controversial "puberty blockers" are set to be "indefinitely" banned in the UK, the Department for Health and Social Care has said. Wes Streeting's department announced that the treatments - clinical ...

Puberty blockers for under 18s with gender dysphoria with be banned indefinitely in the UK because of an “unacceptable safety risk”, the Department of Health and Social Care, led by Wes Streeting, has ...